Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-20 of 77
Keywords: Chronic myeloid leukemia
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Philipp le Coutre, Andreas Burchert, Susanne Saußele, Thekla Schwarzer, Sebastian Stintzing, Uwe Pelzer, Lars Bullinger, Ahmet Elmaagacli, Christian Jehn, Frank Stegelmann, Andreas Hochhaus, Thomas Ernst, Joachim R. Göthert
Journal:
Acta Haematologica
Acta Haematol (2025)
Published Online: 05 May 2025
...Philipp le Coutre; Andreas Burchert; Susanne Saußele; Thekla Schwarzer; Sebastian Stintzing; Uwe Pelzer; Lars Bullinger; Ahmet Elmaagacli; Christian Jehn; Frank Stegelmann; Andreas Hochhaus; Thomas Ernst; Joachim R. Göthert Introduction: In chronic myeloid leukemia patients, second-line treatment...
Journal Articles
Real-World Experience in the Management of Chronic Myeloid Leukemia Patients Focused on Tyrosine Kinase Inhibitors Intolerance and Health-Related Quality of Life
Available to Purchase
Journal:
Acta Haematologica
Acta Haematol (2025)
Published Online: 10 January 2025
... of life (HRQoL) in patients with chronic myeloid leukemia (CML). Methods: Medical records of 345 patients with CML treated with at least one type of TKI were retrospectively reviewed. Results: No significant differences in survival were observed based on the number of different TKIs the patients received...
Journal Articles
Sudden Blast Crisis in a Chronic Myeloid Leukemia Patient in Treatment-Free Remission: A Case Report and Literature Review
Available to Purchase
Journal:
Acta Haematologica
Acta Haematol 1–8.
Published Online: 21 October 2024
...Qiushi Liang; Zhigang Liu; Yu Wu; Huanling Zhu; Yunfan Yang Introduction: Treatment-free remission (TFR) has emerged as a new goal in the treatment of chronic myeloid leukemia (CML). TFR is considered a safe intervention because patients who experienced molecular relapse usually responded well...
Journal Articles
Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy
Available to PurchaseAlessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, Chiara Elena, Mariella D'Adda, Elena Agostani, Cristina Fiamenghi, Margherita Maffioli, Nicola Orofino, Francesca Lunghi, Angelo Gardellini, Maria Cristina Carraro, Alessandro Inzoli, Federica Gigli, Roberto Palazzolo, Vanda Bertolli, Daniele Cattaneo, Ester Maria Pungolino, Carlo Gambacorti-Passerini
Journal:
Acta Haematologica
Acta Haematol 1–5.
Published Online: 18 September 2024
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Adverse events Bosutinib Chronic myeloid leukemia Tyrosine kinase inhibitors Tyrosine kinase inhibitors (TKIs) ensure that most patients with chronic myeloid leukemia...
Journal Articles
Failure of Treatment-Free Remission after a Prolonged Deep Molecular Response in Patients with Chronic Myeloid Leukemia
Available to PurchasePatrice E. Nasnas, Elias J. Jabbour, Koji Sasaki, Ghayas C. Issa, Lucia Masarova, Nicholas J. Short, Fadi G. Haddad
Journal:
Acta Haematologica
Acta Haematol (2025) 148 (1): 105–110.
Published Online: 04 April 2024
...Patrice E. Nasnas; Elias J. Jabbour; Koji Sasaki; Ghayas C. Issa; Lucia Masarova; Nicholas J. Short; Fadi G. Haddad Introduction: Treatment discontinuation and treatment-free remission (TFR) emerged as the new goal of therapy in patients with chronic myeloid leukemia in chronic phase (CML-CP...
Journal Articles
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia
Open AccessSusanne Saussele, Paul La Rosée, Alexander Kiani, Wilhelm Haverkamp, Kathleen Jentsch-Ullrich, Frank Stegelmann, Christina Rieger, Cornelius F. Waller, Georg-Nikolaus Franke, Christian Junghanss, Rudolf Kirchmair, Markus Theurl, Philipp le Coutre
Journal:
Acta Haematologica
Acta Haematol (2024) 147 (3): 344–351.
Published Online: 17 October 2023
.... 2023 Chronic myeloid leukemia Ponatinib Dosing regimens Cardiovascular management Consensus paper According to the ELN recommendations 2020, the third-generation tyrosine kinase inhibitor (3G TKI) ponatinib is currently the most potent TKI used in CML [ 1 ]. Ponatinib is effective...
Journal Articles
A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity
Available to PurchaseMaria Efstathopoulou, Katerina Zoi, Marina P. Siakantaris, Daphne Koumbi, Anna Zannou, Evangelia-Faidra Triantafyllou, Gerassimos Tsourouflis, Eleftheria Lakiotaki, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou
Journal:
Acta Haematologica
Acta Haematol (2023) 146 (6): 531–539.
Published Online: 09 August 2023
... to in the content or advertisements. 2023 T-cell blast crisis Chronic myeloid leukemia Allogeneic bone marrow transplantation The Philadelphia chromosome (t(9; 22) (q34; q11)) is the hallmark of chronic myelogenous leukemia (CML) but is also present in 15–30% of adult B-cell acute lymphoblastic...
Journal Articles
An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia after Experiencing Pleural Effusion during Dasatinib Therapy
Available to Purchase
Journal:
Acta Haematologica
Acta Haematol (2023) 146 (4): 259–266.
Published Online: 10 April 2023
...Ali McBride; John Brokars; Sheila Reiss Reddy; Eunice Chang; Marian H. Tarbox; Thomas W. LeBlanc Introduction: Treatment with dasatinib for chronic myeloid leukemia (CML) has been associated with development of pleural effusion; however, data regarding its optimal management are limited. We...
Journal Articles
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective
Available to PurchaseFrancesco Tarantini, Cosimo Cumbo, Elisa Parciante, Luisa Anelli, Antonella Zagaria, Nicoletta Coccaro, Crescenzio Francesco Minervini, Giuseppina Tota, Immacolata Redavid, Maria Rosa Conserva, Immacolata Attolico, Antonella Russo Rossi, Giorgina Specchia, Pellegrino Musto, Francesco Albano
Journal:
Acta Haematologica
Acta Haematol (2023) 146 (1): 39–45.
Published Online: 14 March 2023
... to treatment. Methods: We evaluated the IRF4 expression kinetics during tyrosine kinase inhibitor (TKI) treatment in a cohort of 116 chronic myeloid leukemia (CML) patients to elucidate its role in the disease course. Results: A relationship between the IRF4 expression and the disease burden was observed...
Journal Articles
Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia
Available to PurchaseTamar Berger, Adi Shacham Abulafia, Shai Shimony, Oren Pasvolsky, Iuliana Vaxman, Yifat Miron, Shimrit Feldman, Avi Leader, Pia Raanani
Journal:
Acta Haematologica
Acta Haematol (2022) 145 (6): 619–626.
Published Online: 29 July 2022
...Tamar Berger; Adi Shacham Abulafia; Shai Shimony; Oren Pasvolsky; Iuliana Vaxman; Yifat Miron; Shimrit Feldman; Avi Leader; Pia Raanani Introduction: Data regarding the prevalence of paraproteinemia in patients with chronic myeloid leukemia (CML) are lacking. Methods: To evaluate for the prevalence...
Journal Articles
Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology Practices
Available to PurchaseJolanta Dengler, Hans Tesch, Kathleen Jentsch-Ullrich, Anke Gerhardt, Clemens Schulte, Jörg Lipke, Gunnar Löwe, Alexander Kiani
Journal:
Acta Haematologica
Acta Haematol (2022) 145 (6): 603–610.
Published Online: 29 July 2022
...Jolanta Dengler; Hans Tesch; Kathleen Jentsch-Ullrich; Anke Gerhardt; Clemens Schulte; Jörg Lipke; Gunnar Löwe; Alexander Kiani Introduction: Treatment-free remission (TFR) is increasingly considered as treatment goal for patients with chronic myeloid leukemia (CML), but information...
Journal Articles
Acquired Factor V Deficiency: A New Cause of Bleeding in Patients with Chronic Myeloid Leukemia and Extreme Leukocytosis
Available to Purchase
Journal:
Acta Haematologica
Acta Haematol (2023) 146 (6): 546–549.
Published Online: 02 May 2022
...An Quoc To; Stefan O. Ciurea; Piyanuch Kongtim Bleeding complications in patients with myeloproliferative neoplasms are known to be related to acquired von Willebrand disease or platelet dysfunction. Here, we describe two very similar cases of chronic phase chronic myeloid leukemia with extreme...
Journal Articles
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer
Available to PurchaseMarisa J.L. Aitken, Christopher B. Benton, Ghayas C. Issa, Koji Sasaki, Musa Yilmaz, Nicholas J. Short
Journal:
Acta Haematologica
Acta Haematol (2021) 144 (5): 585–590.
Published Online: 18 March 2021
... and report on their environmental exposures that may have contributed to CML pathogenesis. The possible familial association of these 2 cases of CML warrants further investigation into more definitive etiologies of this disease. Chronic myeloid leukemia Hereditary cancer syndromes Familial cancer...
Journal Articles
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias
Available to PurchaseAbhishek Maiti, Miguel J. Franquiz, Farhad Ravandi, Jorge E. Cortes, Elias J. Jabbour, Koji Sasaki, Kayleigh Marx, Naval G. Daver, Tapan M. Kadia, Marina Y. Konopleva, Lucia Masarova, Gautam Borthakur, Courtney D. DiNardo, Kiran Naqvi, Sherry Pierce, Hagop M. Kantarjian, Nicholas J. Short
Journal:
Acta Haematologica
Acta Haematol (2020) 143 (6): 567–573.
Published Online: 09 February 2021
... Background: Philadelphia chromosome-positive (Ph+) advanced leukemias, including acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) in myeloid blast phase (MBP), have poor outcomes. Venetoclax has shown synergism with BCR-ABL1 tyrosine kinase inhibitors (TKI) in preclinical studies. However...
Journal Articles
Susanne Saussele, Wilhelm Haverkamp, Fabian Lang, Steffen Koschmieder, Alexander Kiani, Kathleen Jentsch-Ullrich, Frank Stegelmann, Heike Pfeifer, Paul La Rosée, Nicola Goekbuget, Christina Rieger, Cornelius F. Waller, Georg-Nikolaus Franke, Philipp le Coutre, Rudolf Kirchmair, Christian Junghanss
Journal:
Acta Haematologica
Acta Haematol (2020) 143 (3): 217–231.
Published Online: 07 October 2019
... Treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute leukemia (Ph+ ALL) has been revolutionized with the advent of tyrosine kinase inhibitors (TKIs). Most patients with CML achieve long-term survival similar to individuals without CML due to treatment with TKIs not only...
Journal Articles
Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Available to PurchasePan Pan, Lijuan Wang, Yanjun Wang, Li Shen, Pingping Zheng, Chunli Bi, Anning Zhang, Yaogai Lv, Zhiqiang Xue, Mengzi Sun, Chong Sun, Jiagen Li, Lina Jin, Yan Yao
Journal:
Acta Haematologica
Acta Haematol (2020) 143 (3): 204–216.
Published Online: 12 September 2019
... (NG-TKIs; including dasatinib, nilotinib, bosutinib, radotinib, and ponatinib) versus imatinib for patients with newly diagnosed chronic myeloid leukemia (CML). Summary: We identified randomized controlled trials comparing the efficacy of NG-TKIs versus imatinib as the first-line treatment for CML...
Journal Articles
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience
Available to PurchaseFiorina Giona, Michelina Santopietro, Giuseppe Menna, Maria Caterina Putti, Concetta Micalizzi, Nicola Santoro, Ottavio Ziino, Rosamaria Mura, Saverio Ladogana, Grazia Iaria, Antonella Sau, Roberta Burnelli, Nadia Vacca, Sayla Bernasconi, Caterina Consarino, Fara Petruzziello, Maria Luisa Moleti, Andrea Biondi, Franco Locatelli, Robin Foà
Journal:
Acta Haematologica
Acta Haematol (2018) 140 (2): 105–111.
Published Online: 18 September 2018
...; Andrea Biondi; Franco Locatelli; Robin Foà Background: To date, no data on the adherence to specific guidelines for children with chronic myeloid leukemia (CML) in chronic phase (CP) have been reported. Methods: Since 2001, guidelines for treatment with imatinib mesylate (IM) and monitoring in patients...
Journal Articles
Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients
Available to PurchasePavlina Ptackova, Martina Petrackova, Miroslav Hindos, Martina Duskova, Eva Hamsikova, Hana Klamova, Pavla Pecherkova, Zuzana Humlova, Vladimir Vonka
Journal:
Acta Haematologica
Acta Haematol (2017) 137 (3): 148–157.
Published Online: 05 April 2017
... stimulated CD3+ cells from 38 chronic myeloid leukemia (CML) patients. At the time of diagnosis the percentages of cells producing INF-γ, TNF-α, and IL-2 were strongly suppressed compared to those in healthy control subjects. Hematological remission achieved through treatment with tyrosine-kinase inhibitors...
Journal Articles
Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response
Available to PurchaseFiorenzo Santoleri, Ruggero Lasala, Elena Ranucci, Gaetano La Barba, Roberto Di Lorenzo, Antonio Vetrò, Paolo Di Bartolomeo, Alberto Costantini
Journal:
Acta Haematologica
Acta Haematol (2016) 136 (1): 45–51.
Published Online: 10 May 2016
... as weighted mean of RDD, were 0.35 ± 0.10 g in year 1 and 0.35 ± 0.08 g in year 2, and mean PDD values are 0.38 ± 0.07 and 0.37 ± 0.06 g, respectively. Table 4 Outcome with respect to adherence cutoffs Chronic myeloid leukemia (CML) is a clonal disease of hematopoietic stem cells...
Journal Articles
Overexpression of CCAAT Enhancer-Binding Protein α Inhibits the Growth of K562 Cells via the Foxo3a-Bim Pathway
Available to Purchase
Journal:
Acta Haematologica
Acta Haematol (2016) 136 (2): 65–70.
Published Online: 10 May 2016
...Guili Zhang; Fei Dong; Caifu Luan; Xia Zhang; Huiyuan Shao; Jie Liu; Chengming Sun We aimed to investigate the role of CCAAT enhancer-binding protein α (C/EBPα) in the pathogenesis of chronic myeloid leukemia (CML) and the mechanism underlying its effect. Bone marrow specimens from 50 patients...
1